Licart Reimbursement Guide
IBSA Pharma Inc. has developed this resource to support healthcare professionals (HCPs) navigate coverage, coding, and insurance coverage for Licart® (diclofenac epolamine) topical system 1.3%. The information in this Reimbursement Guide is intended solely as a resource to assist the staff in physicians’ offices with certain insurance-related questions for Licart®.
Sample Letters of Medical Necessity and Appeal for Insurance Provider
Provided below are downloadable templates to reference and utilize at your convenience for insurance providers on behalf of Licart®. These are not to be sent as is, fill in patient information as needed since these are not complete letters.